Published on 14 Jan 2022 on Insider Monkey via Yahoo Finance

Hedge Fund Sentiment Is Stagnant On Novartis AG (NVS)

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period that ended September 30th, so let’s proceed with the discussion of the hedge fund sentiment on Novartis AG (NYSE:NVS).

Novartis AG (NYSE:NVS) shares haven't seen a lot of action during the second quarter. Overall, hedge fund sentiment was unchanged. The stock was in 22 hedge funds' portfolios at the end of the third quarter of 2021. Our calculations also showed that NVS isn't among the 30 most popular stocks among hedge funds (click for Q2 rankings). At the end of this article we will also compare NVS to other stocks including McDonald's Corporation (NYSE:MCD), Morgan Stanley (NYSE:MS), and Texas Instruments Incorporated (NASDAQ:TXN) to get a better sense of its popularity.

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium prices have more than doubled over the past year, so we go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. With all of this in mind let's view the recent hedge fund action encompassing Novartis AG (NYSE:NVS).